Health and Medical Devices News
Sub-Analysis Shows Primary Benefits seen with RE-LY® are Independent of Level of Centre-Based International Normalized Ratio Control
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced that results from a pre-specified sub-group analysis of the RE-LY® study (Randomized Evaluation of Long-Term Anticoagulation Therapy, Warfarin, Compared with Dabigatran) – the largest atrial fibrillation outcomes trial ever completed - were published in The Lancet. 1 The sub-group analysis assessed the effects of centre-based international normalized ratio (INR) control on study outcomes. "These findings support the superi
…
Invacare Corporation Responds to Governor Ted Strickland’s Campaign Ad Criticizing the Company
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation Responds to Governor Ted Strickland's Campaign Ad Criticizing the Company. Invacare has added approximately 200 associates to its Ohio campus in recent years.
…
BayBio Files Amicus Brief in Matrixx Case before the Supreme Court
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Today, BayBio submitted a brief as amicus curiae (friend of the court) in the Supreme Court of the United States in the case of Matrixx Initiatives Inc. v. James Siracusano. The case concerns whether the failure to disclose non-statistically significant adverse event data can give rise to fraud claims under federal securities laws. "BayBio represents the largest cluster of life sciences companies in the world, and they are dedicated to the developmen
…
Hip Replacement Lawsuit Veterans at The Lanier Law Firm Providing Information on Latest Recall from Johnson & Johnson
LOS ANGELES--(BUSINESS WIRE)--Hip implant recall information available at www.recalledhip.com. Johnson & Johnson hip implant recall affects thousands of patients.
…
El Camino Hospital Offers Revolutionary New Asthma Treatment
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--El Camino Hospital becomes one of the first hospitals nationwide to offer bronchial thermoplasty, a just-approved permanent treatment for patients who suffer severe, uncontrolled asthma.
…
Double Hand Transplant Recipient See Hands for First Time at Jewish Hospital
LOUISVILLE, Ky.--(BUSINESS WIRE)--Dr. Richard Edwards, the recipient of a double hand transplant at Jewish Hospital in Louisville, got a look at his new hands today when all the bandages were removed so doctors could evaluate healing.
…
Research and Markets: Israel Surgical Equipment Market Outlook to 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/e5febd/israel_surgical_eq) has announced the addition of GlobalData's new report "Israel Surgical Equipment Market Outlook to 2016" to their offering. Israel Surgical Equipment Market Outlook to 2016 Summary Our medical devices report, Israel Surgical Equipment Market Outlook to 2016 provides key market data on the South Africa Surgical Equipment market. The report provides value (USD million), volume (unit
…
Research and Markets: Spain Surgical Equipment Market Outlook to 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9257b4/spain_surgical_equ) has announced the addition of GlobalData's new report "Spain Surgical Equipment Market Outlook to 2016" to their offering. Spain Surgical Equipment Market Outlook to 2016 Summary Our medical devices report, Spain Surgical Equipment Market Outlook to 2016 provides key market data on the Spain Surgical Equipment market. The report provides value (USD million), volume (units) and ave
…
Research and Markets: Netherlands Opthalmic Devices Market Outlook to 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c6b491/netherlands_opthal) has announced the addition of GlobalData's new report "Netherlands Opthalmic Devices Market Outlook to 2016" to their offering. Netherlands Opthalmic Devices Market Outlook to 2016 Summary Our medical devices report, Netherlands Opthalmic Devices Market Outlook to 2016 provides key market data on the Netherlands ophthalmic devices market. The report provides value (USD million), v
…
VertiFlex®, Inc. Announces Sale of Percutaneous Fusion Portfolio
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc. Announces Sale of Percutaneous Fusion Portfolio. Silverbolt® Platform Divested to Exactech, Inc.
…
Biomagnetics Announces LOI to Acquire Hubei Tianyuan Chemical Company–Third Chinese Asset Targeted at $1.50 BMGP Share Price
SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Hubei Tianyuan Chemical Co., Ltd. of Yangxin Nacheng Chemical Industry Zone, located in Hubei Province, China. This expected acquisition is the third of several planned acquisitions targeted at a
…
Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.
BRENTWOOD, N.Y.--(BUSINESS WIRE)--Medical Action Industries Inc. (NASDAQ: MDCI) announced the acquisition of AVID Medical, Inc., a leading provider of custom procedure trays serving the healthcare industry. AVID’s product line of custom procedure trays is complementary to Medical Action’s leading position in single use medical products. Medical Action expects that the acquisition will increase its ability to serve healthcare providers in acute care facilities and surgery centers. The combined co
…
Zynex Announces New Chief Financial Officer
LITTLETON, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Anthony Scalese has been named Chief Financial Officer. Mr. Scalese will start on September 7, 2010, and will report directly to Thomas Sandgaard, Chief Executive Officer. Mr. Scalese has over 15 years of experience in accounting, finance and operations and has spent the past 13 years of his career in the h
…
Exactech Acquires Minimally Invasive Spine Reconstruction Portfolio
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech acquired spine implant product lines for minimally invasive spinal surgeries. In addition to motion preserving spinal surgery products, Exactech offers cervical and lumbar fusion solutions.
…
诺华公司完成对雀巢所持爱尔康多数股权的收购
瑞士HUENENBERG--(BUSINESS WIRE)--(美国商业资讯)--诺华公司(NYSE: NVS)和瑞士雀巢公司今日宣布，他们已完成爱尔康公司(NYSE: ACL)约 1.56亿股股份（283亿美元）的购买和销售。 此交易依据雀巢公司和诺华公司于2008年4月6日所签协议而完成。完成此交易后，诺华公司成为目前爱尔康的最大股东，约控爱尔康已发行股票的77%。即时生效后，爱尔康董事会中的五名雀巢公司的指派成员已递交辞呈，诺华公司于2010年8月16日指派的五名董事会成员则走马上任。 爱尔康总裁兼首席执行官Kevin Buehler说：“我非常感谢雀巢公司30多年来给予爱尔康公司的杰出贡献和支持，这为爱尔康成长为眼科产品全球领头羊起了重要作用。现在我们非常欢迎诺华公司成为我们新的最大股东。我们期待与诺华携手，进一步加强爱尔康的业务模式，提供更多的成长机会，为全球的客户和患者带来更多的利益。” 雀巢公司和诺华公司所宣布的此项交易并不影响剩余的在纽约证券交易所公开交易的23%股份。2010年1月4日，诺华公司提出依据瑞士法律，以2.8股诺华公司股份兑换1股爱尔康股份（目前市值约14
…
Research and Markets: Germany Opthalmic Devices Market Outlook to 2016 - Key Market Data on the Germany Ophthalmic Devices Market
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b3640f/germany_opthalmic) has announced the addition of GlobalData's new report "Germany Opthalmic Devices Market Outlook to 2016" to their offering. Our medical devices report, Germany Opthalmic Devices Market Outlook to 2016 provides key market data on the Germany ophthalmic devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segmen
…
Charles River Implements $300 Million Accelerated Stock Repurchase Program
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River implements $300 million accelerated stock repurchase program (ASR) and announces $750 million credit facility
…
Del Medical, Inc. Wins Mexican Tender
ROSELLE, Ill.--(BUSINESS WIRE)--Del Medical, Inc. ("Del Medical" or "the Company") today announced they were recently awarded a Mexican tender from IMSS (Instituto Mexicano del Seguro Social) for over twenty complete Del Medical DR radiographic rooms valued in excess of $2 million. Each 50kw, floor-mounted tube stand system is equipped with Del’s popular EV650 elevating, four-way, float top table and bundled with a DelWorks Medical DR package. Each package includes a 14” x 17” portable flat pane
…
ノバルティスがネスレからアルコンの過半数株式の買い取りを完了
スイス・ヒューネンベルク--(BUSINESS WIRE)--（ビジネスワイヤ） -- ノバルティス（NYSE: NVS）とネスレは本日、現金283億米ドルによるアルコン（NYSE: ACL）株式約1億5600万株の売買を完了したと発表しました。 この取引は、2008年4月6日にネスレとノバルティスとの間で締結された契約に基づいて完了しました。この取引の完了に伴い、ノバルティスはアルコンの多数株主となり、アルコンの発行済み株式の約77パーセントを保有することになります。同日、ネスレが指名していたアルコンの取締役5人が辞任願を提出し、2010年8月16日に行われたノバルティス指名の5人の取締役の選任の効力発生が想定されています。 アルコンの社長兼最高経営責任者（CEO）のケビン・ビューラーは、次のように述べています。「ネスレには、30年以上にわたるアルコンへの多大な貢献とご支援に感謝します。ネスレには、アルコンが眼科治療分野における世界的リーダーとなる上で大きな役割を果たしていただけました。今回、当社はノバルティスを新たな多数株主に迎えました。ノバルティスと共にアルコンのビジネスモデルを
…
Novartis completa la compra a Nestlé de intereses mayoritarios en Alcon
HUENENBERG, Suiza--(BUSINESS WIRE)--Novartis AG (NYSE: NVS) y Nestlé S.A. anunciaron hoy que han completado la compraventa de aproximadamente 156 millones de acciones de Alcon, Inc. (NYSE: ACL) por un valor de 28.300 millones de dólares estadounidenses en efectivo. La transacción se completó conforme a un acuerdo entre Nestlé y Novartis celebrado el 6 de abril de 2008. Con la finalización de esta transacción, Novartis es actualmente el accionista mayoritario de Alcon y controla aproximadamente e
…
